PSMA-Targeted Therapy in Prostate Cancer
10.2 هزار بار بازدید -
3 سال پیش
-
To learn more about the
To learn more about the top medical innovations for 2022, please visit https://cle.clinic/3GPe1c9
Each year, more than 200,000 American men receive a diagnosis of prostate cancer – making it the most commonly diagnosed cancer among men in the United States. Accurate imaging is critical for tumor localization, staging the disease and detecting recurrences. PSMA, an antigen found in high levels on the surface of prostate cancer cells, is a potential biomarker for the disease. PMSA PET scans use a radioactive tracer to attach to PSMA proteins, which are then combined with CT or MRI scans to visualize the location of prostate cancer cells. In 2020, this technology received FDA approval based on Phase III clinical trials, which showed substantially increased accuracy for detecting prostate cancer metastasis compared to conventional imaging with bone and CT scans. When detected early by PSMA PET scans, recurrent prostate cancer can be treated through a targeted approach with stereotactic body radiation therapy, surgery and/or systemic therapy in a personalized manner.
▶Share this video with others: PSMA-Targeted Therapy in Prostate Cancer
▶Subscribe to learn more about Cleveland Clinic:
https://www.youtube.com/user/Clevelan...
#ClevelandClinic #MedicalInnovations
Each year, more than 200,000 American men receive a diagnosis of prostate cancer – making it the most commonly diagnosed cancer among men in the United States. Accurate imaging is critical for tumor localization, staging the disease and detecting recurrences. PSMA, an antigen found in high levels on the surface of prostate cancer cells, is a potential biomarker for the disease. PMSA PET scans use a radioactive tracer to attach to PSMA proteins, which are then combined with CT or MRI scans to visualize the location of prostate cancer cells. In 2020, this technology received FDA approval based on Phase III clinical trials, which showed substantially increased accuracy for detecting prostate cancer metastasis compared to conventional imaging with bone and CT scans. When detected early by PSMA PET scans, recurrent prostate cancer can be treated through a targeted approach with stereotactic body radiation therapy, surgery and/or systemic therapy in a personalized manner.
▶Share this video with others: PSMA-Targeted Therapy in Prostate Cancer
▶Subscribe to learn more about Cleveland Clinic:
https://www.youtube.com/user/Clevelan...
#ClevelandClinic #MedicalInnovations
3 سال پیش
در تاریخ 1400/11/27 منتشر شده
است.
10,223
بـار بازدید شده